Israel Active

Israel’s “Shining Star” field hospital has been established by the Israel Ministry of Foreign Affairs, the Ministry of Health, and Sheba Medical Centre, assisted by Israel’s healthcare system. In its first week it treated 1,100+ adults and children, including a 10-year-old heart patient.

Israeli HMO Clalit, Sapir College and Ben-Gurion University studied 563,465 Israelis aged 60-100 who were eligible for the fourth coronavirus vaccine. They reported a 78% decrease in COVID deaths. In a 40-day period.

Ben Gurion University’s Dr. Shai Pilosof has won a $100,000 grant from the International Human Frontier Science Program Organization (HFSP) for researching animals and environment. His colleague Dr Benjamin Palmer is investigating the diversity of color in the natural world.

Tel Aviv University researchers have discovered that after a minor head injury many children later displayed symptoms that were often misdiagnosed as ADHD. 200 children were monitored and 25% were found to suffer chronic persistent post-concussion syndrome, requiring much different treatment.

Researchers at Ben-Gurion University have developed an innovative treatment for Head & Neck Cancer (HNC) sufferers. It blocks the hyper-activation of a specific cell-signaling pathway that is found in over 40% of HNC patients.

The huge numbers of Israeli volunteers aiding refugees from Ukraine in Moldova include the medical clowns of Dream Doctors (see previously). Their costumes, big red noses and funny antics light up the faces of exhausted Ukrainian women, children, and elderly men.

Israel airlifted some 17 tons of equipment to build its $6.5 million “Kochav Meir” (Shining Star) Ukraine field hospital (see previously), which is expected to treat around 100 patients per day. Also, Magen David Adom is sending 4 bullet-proof ambulances to Ukraine.

Ziv Medical Center in Tzfat (Safed) is currently offering AMOR-18 from Israel’s Amorphical (see previously) to all moderate to serious COVID-19 patients. It is also undergoing clinical trials at four Israeli hospitals. All 18 patients in Ziv’s trials of AMOR-18 recovered quickly.

4-year-old Feiga arrived in Israel from Ukraine, unable to eat due to her poor dental condition. Just 24 hours after contacting Dental Volunteers for Israel, Feiga had root canal treatment to alleviate her pain, while pediatric dentists gently prepared her for further treatment.

Israel’s OncoHost (see previously) has opened a new laboratory in North Carolina for its PROphet blood test to identify which cancer treatments are likely to work. Israeli Nobel Prize winner Aaron Ciechanover is an OncoHost’s advisor. PROphet may also help autoimmune disease sufferers.